InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

CKPT Stock Earnings: Checkpoint Therapeutics Beats EPS, Beats Revenue for Q2 2024

CKPT stock results show that Checkpoint Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024

ATOS stock results show that Atossa Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

APRE Stock Earnings: Aprea Therapeutics Beats EPS, Beats Revenue for Q2 2024

APRE stock results show that Aprea Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

TORO Stock Earnings: Toro Reported Results for Q2 2024

Toro just reported results for the second quarter of 2024.

LFCR Stock Earnings: Lifecore Biomedical Beats EPS, Beats Revenue for Q2 2024

LFCR stock results show that Lifecore Biomedical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.